MedPath

PHARMLINE MARKETING PTE. LTD.

🇸🇬Singapore
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

13

HSA:13

Drug Approvals

DYMISTA NASAL SPRAY

Approval Date
Jun 5, 2017
HSA

SYNAZE NASAL SPRAY

Approval Date
Jun 5, 2017
HSA

BELARA film-coated tablet 0.03mg/2mg

Approval Date
Oct 14, 2015
HSA

Spasmolyt Tablet 20mg

Approval Date
Jul 6, 2007
HSA

Trachisan Forte Lozenge

Approval Date
May 17, 2007
HSA

ELIDEL CREAM 1% w/w

Approval Date
Jan 31, 2003
HSA

POSTINOR 2 TABLET 0.75 mg

Approval Date
Mar 5, 2002
HSA

FLUVOXAMINE MALEATE TABLET 50 mg

Approval Date
Feb 26, 2002
HSA

CLOZAPINE TABLET 25 mg

Approval Date
Apr 26, 2001
HSA

ZOPICLONE TABLET 7.5 mg

Approval Date
Oct 27, 2000
HSA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.